Avadel Pharmaceuticals PLC (NASDAQ:AVDL)
| 7.38 Delayed Data As of Jan 27 |  -0.09 / -1.20%Today’s Change | 1.05 Today|||52-Week Range 10.02 | +3.07% Year-to-Date |
Latest AVDL News | Press Releases
No recent news for Avadel Pharmaceuticals PLC.
Today’s Trading
| Previous close | 7.47 |
| Today’s open | 7.44 |
| Day’s range | 7.31 - 7.61 |
| Volume | 134,105 |
| Average volume (3 months) | 637,831 |
| Market cap | $447.9M |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -1,096.30% |
| Earnings growth (this year) | -49.32% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABUSArbutus Biopharma Co... | 0.00 | 0.00% |
| ---- | ||
| EGRXEagle Pharmaceutical... | -0.02 | -0.06% |
| ---- |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | March 7, 2023 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$77.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
